文献速递艾滋病与性传播感染

美国商业保险人群HIV暴露前预防用药 uptake 2010-2014

Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014.
PubMed 文献 · Clin Infect Dis · 2016-10-19

该研究基于2010-2014年MarketScan商业保险数据库,开发算法识别每年接受TDF-FTC用于HIV暴露前预防(PrEP)的≥16岁人群,并生成全国代表性患病率估计。结果显示PrEP使用者从2010年417人增至2014年9375人(P < .001),2014年97%为男性、98%居住于大都市区,女性使用者数量始终很低。结论认为需干预以增加高风险女性PrEP使用。

要点

  • 2010-2014年美国商业保险人群PrEP处方呈显著上升趋势,使用者从417人增至9375人。
  • 2014年PrEP使用者中97%为男性,98%居住于大都市区。
  • 研究期间女性PrEP使用者数量很低,需干预促进高风险女性使用。

核心结论

  • 商业保险人群中PrEP使用呈显著上升趋势,但女性使用数量始终很低。

研究设计与样本

  • 回顾性分析2010-2014年MarketScan商业健康保险数据库,开发算法识别每年接受TDF-FTC用于PrEP的≥16岁人群。

主要发现

  • PrEP使用者从2010年417人增至2014年9375人(P < .001)。
  • 2014年97%的PrEP使用者为男性,98%居住于大都市区。
  • 研究期间女性PrEP处方数量很低。

临床怎么用

  • 该分析方法可用于在美国监测PrEP uptake。
  • 需针对高风险女性采取干预措施以提高PrEP使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Daily, oral use of tenofovir disoproxil fumarate and emtricitabine (TDF-FTC) for preexposure prophylaxis (PrEP) is an effective strategy to prevent acquisition of human immunodeficiency virus (HIV) infection. It is important to monitor PrEP uptake at the national level to increase our understanding of trends in its utilization, but national HIV surveillance data do not include PrEP uptake. Our objective was to develop feasible methods to estimate PrEP uptake and to estimate uptake each year among commercially insured persons during 2010-2014. METHODS: We conducted a retrospective analysis of the 2010-2014 MarketScan database, a national sample of persons with commercial health insurance in the United States. We developed an algorithm to identify persons aged ≥16 years who were prescribed TDF-FTC for PrEP each year. We generated nationally representative estimates of prevalence of persons prescribed PrEP. RESULTS: We found a significantly increasing trend in the proportion of persons prescribed TDF-FTC for PrEP during the study period, with 417 users in 2010 and 9375 in 2014 (P < .001); 97% of PrEP users were male and 98% lived in metropolitan areas in 2014. During the study period, the numbers of women prescribed PrEP were low. CONCLUSIONS: Our analytic method provides the only feasible means to monitor PrEP uptake in the United States. Although a marked increasing trend in uptake was observed for men, the number of women who used PrEP remained very low during the study period. Interventions are needed to increase PrEP use by women at substantial risk of acquiring HIV infection.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wu H, Mendoza MC, Huang YA, et al. Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014. Clin Infect Dis. 2016. PMID: 27986691. doi:10.1093/cid/ciw701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。